SEC Filings for Ligand Pharmaceuticals Incorporated (LGND)

$ 102.24   0.67 (+0.66%) Volume: 311.36k 4:00 PM EDT 1-Jun-2020
Filing Type:
Form TypeForm DescriptionPagesDateView
8-KCurrent report pursuant to Section 13 or 15(d)305/10/2018
10-QGeneral form for quarterly reports under Section 13 or 15(d)8305/09/2018
8-KCurrent report pursuant to Section 13 or 15(d)1205/08/2018
DEFA14AAdditional proxy soliciting materials - definitive504/30/2018
DEF 14AOther definitive proxy statements5404/30/2018
8-KCurrent report pursuant to Section 13 or 15(d)304/13/2018
CT ORDERConfidential treatment order104/03/2018
4Statement of changes in beneficial ownership of securities104/03/2018
8-KCurrent report pursuant to Section 13 or 15(d)303/22/2018
4Statement of changes in beneficial ownership of securities103/13/2018
4Statement of changes in beneficial ownership of securities103/09/2018
8-K/A[Amend]Current report pursuant to Section 13 or 15(d)403/07/2018
4Statement of changes in beneficial ownership of securities103/06/2018
4Statement of changes in beneficial ownership of securities103/06/2018
4Statement of changes in beneficial ownership of securities103/06/2018
67891011121314151617181920